Study details
Enrolling now
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
University of Pennsylvania
NCT IDNCT06954129ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Ages
18+
Locations
1 site in PA
What this study is about
This Phase 4 study is testing Cefepime in people with acute kidney injury.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IVInjection / IV
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
cefepime, antibiotic (Extended-spectrum penicillin + beta-lactamase inhibitor), vancomycin
Drug routes
injection (Injection), infusion
Endpoints
Secondary: Serum creatinine concentration
Body systems
Renal